Atelerix today announced a partnership with Cherry Biotech, bringing together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in the preclinical research and biotech sectors. Read more: rb.gy/ver8ru

EpilepsyGTx has raised $33 million in Series A financing to advance its lead gene therapy programme EPY201 through Phase 1/2a clinical trials. The round included investment from XGEN Venture, the British Business Bank, and a global biopharmaceutical company: www.epilepsygtx.com/news/epileps...

Enterprise Therapeutics has published results of its Phase 1 study of ETD001 in the Journal of Cystic Fibrosis, demonstrating that ETD001 is well tolerated in healthy individuals at higher doses than predicted to be therapeutic. bit.ly/44JW11K

VALANX Biotech today announced the formation of its Board of Directors, bringing together industry leaders to support the company's strategic direction as VALANX advances from a research-stage organisation into clinical development and technology commercialisation. Read more: bit.ly/3Y2voS9

This morning, Lab Thread announced the beta release of its flagship platform, a unified lab software designed to simplify and streamline collaboration across biological research. Read the full press release here: bit.ly/48DZXlH

This morning, Atelerix announced a new partnership with Labskin, a global leader in laboratory-grown human skin models, to enable the long distance transport of Labskin's advanced in vitro skin models. Read the full press release: bit.ly/4iG9pKc

Today @trimtechtx.bsky.social announced the appointment of Alison Lawton as Chair of its Board of Directors, bringing substantial expertise in operations and drug development to support TRIMTECH’s accelerated portfolio advancement and next stage of growth ➡️ shorturl.at/xXXbC

@sptlabtech.bsky.social has collaborated with PacBio to automate PacBio’s Kinnex full-length RNA-seq library prep on SPT’s firefly platform. Validated at Seattle Children’s Genomics & Spatial Biology CoLab, the workflow improves reproducibility and scalability: bit.ly/4ianz63

Scottish Brain Sciences today announced that it has opened a new state-of-the-art clinical research centre at #ONEBioHub Aberdeen, a launchpad for start-ups and high potential life science companies looking to rapidly scale and grow. Read more here: bit.ly/4822S7B

Mosaic Tx has appointed Dr Stephen Shuttleworth as CSO to lead its scientific strategy. With over 30 years of experience, Stephen will support the Company to bring its lead products into the clinic and to build out its pipeline of precision oncology programmes: shorturl.at/aNjay

Shift Bioscience released new research detailing an improved framework for evaluating benchmark metric calibration in virtual cell models, reinforcing the use of AI virtual cells to accelerate target identification pipelines. Learn more: shiftbioscience.com/shift-biosci...

Today @trimtechtx.bsky.social announced the appointment of Dr Mike Hutton to its Scientific Advisory Board. Read the full press release here: trimtechtherapeutics.com/trimtech-the...

@sptlabtech.bsky.social and @alitheagenomics.bsky.social have collaborated to provide an automated solution for single-cell transcriptomics, integrating the MERCURIUS FLASH-seq with SPT’s firefly platform for high-throughput, cost efficient single-cell sequencing: www.sptlabtech.com/news/spt-lab...

Today Optibrium introduced the latest release of its comprehensive molecular design platform, StarDrop 8, integrating collaboration at every stage of the discovery process enabling medicinal chemists to progress more quickly from hit to candidate. Read more here: bit.ly/4nGfpn9

Today Nuclera announced expanded access to its eProtein Discovery System for APAC customers through a distributor agreement with Solve Scientific in Australia and New Zealand, providing localised support and expertise to scientists in these regions. bit.ly/3LsJYz3

@proimmune.bsky.social has introduced ProVE SL Self-Loading Class I Monomers, designed to offer unprecedented flexibility, speed and MHC allele-coverage in T cell research, with over 50 alleles available. Read more: www.proimmune.com/news

VALANX Biotech has appointed Klaus Orlinger, PhD. as CSO. Klaus is an experienced R&D leader with a distinguished track record in pharmaceutical product development joining VALANX from HOOKIPA Pharma, where he served as CSO, VP Research, and Head of Virology. Read more here: rb.gy/qva8kz

Today Qureight announced that its Vascul8™ model for pulmonary vascular disorders has been validated in a peer reviewed study, offering the potential to improve treatment options and patient outcomes following surgery. Read the full press release here: bit.ly/48OeEo5

OMED Health, part of @owlstonemedical.bsky.social, has partnered with Aviva to deliver a pilot study, providing 75 Aviva employees with OMED Health Plans. The collaboration will evaluate the impact of the OMED solution on the digestive health of participants: www.owlstonemedical.com/about/news/2...

Biodesix has expanded its partnership agreement with @biorad24.bsky.social to develop in vitro diagnostic assays for highly sensitive detection of genomic markers focused on oncology applications, utilizing Bio-Rad’s ddPCR™ technology & QX600 platform. More here: rb.gy/5wbz3q

@proimmune.bsky.social has expanded into new global headquarters at Oasis Park, Oxford, supporting the continued development of ProImmune’s REVEAL Immunogenicity System and Ankyron target binding technologies. Read more: proimmune.com/news

giles AI has introduced giles, its specialised research agent designed to support healthcare, clinical, and medical research by optimising research intelligence for scientific text comprehension, enabling extraction and summarisation of academic papers: giles.app/press-releas...

Bio-Rad Laboratories today announced that MicroVal, the international certification organization, has approved the iQ-Check Enterobacteriaceae Kit for real time detection of Enterobacteriaceae in infant formula, infant cereal, and related ingredients: www.bio-rad.com/en-uk/life-s...

Today Enamine announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of ASAP-0017445, a promising broad-spectrum coronavirus antiviral pre-clinical candidate. Read more: enamine.net/news-press-r...

.@MosaicTXLtd has appointed Thomas Fuchs as CEO. With over 25 years of experience across drug development and commercialisation, Thomas will lead the Company to advance its pipeline of proprietary drug combination programmes into the clinic: mosaic-tx.com/wp-content/u...

Cyclana Bio today announced the close of a £5M pre-seed funding round that will enable the Company to develop functional disease models and its platform, for the identification of druggable targets in endometriosis. More here: www.cyclanabio.com/general-8

@sptlabtech.bsky.social and @10xgenomics.bsky.social have partnered to provide automated workflows for single cell research, scaling experiments on 10x’s Chromium Single Cell platform using plug-and-play protocols on SPT Labtech’s firefly platform: www.sptlabtech.com/news/spt-lab...

This morning, CN Bio announced the launch of its all-in-one Organ-on-a-chip system, PhysioMimix Core. The system combines the capabilities of CN Bio’s existing suite of instruments, enabling single-, multi-organ and higher-throughput configurations within one scalable platform. bit.ly/3W6HxEv

@sptlabtech.bsky.social and Agilent Technologies have introduced automated targeted enrichment protocols for genomic workflows. The protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kits to increase reproducibility and reduce costs: tinyurl.com/5fmtwuf5

FairJourney Biologics today announced the appointment of Dr. Werner Lanthaler as CEO, who previously served as Evotec SE CEO for 15 years. Founder António Parada will focus on driving the Company's innovation strategy on the Supervisory Board. Read more here: rb.gy/c31dis

Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the POSEIDON program, which aims to develop synthetic-sensor based Multi Cancer-Early Detection (MCED) at-home breath and urine tests: www.owlstonemedical.com/about/news/2...

@bio-rad.bsky.social has announced a strategic agreement with Gencurix that will establish Bio-Rad as the exclusive distributor of Gencurix’ CE-IVD Droplex™ digital PCR oncology testing kits throughout Europe. More here: rb.gy/67rc7e

Tagomics published a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics’ ActivaceTM platform ➡️ bit.ly/4nmE2FU

Miebach Consulting has expanded its facilities at Abingdon Science Park, doubling its footprint with a new bespoke space in The Science Quadrant. Delivered by Kadans Science Partner, the new facilities offer flexible workspaces to support future growth: www.kadans.com/news/miebach...

Today SynGenSys announced the launch of NK.SET™, the first commercially available NK (natural killer) cell-specific promoter library enabling precise and controllable gene expression. Read the full press release here: www.syngensys.com/resources/nk

Today Atelerix announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for research and diagnostics, improving access to its non-cryogenic cell preservation solutions. Read more: shorturl.at/uFlyo

Today @trimtechtx.bsky.social announced it has been named as one of Fierce Biotech’s ‘Fierce 15’ for 2025. The company is creating novel, aggregate-selective, targeted protein degraders to combat neurodegenerative and inflammatory diseases such as Alzheimer’s. Read more: shorturl.at/IRTJO

Today Closed Loop Medicine announced the U.S. launch of WeDosify, the Company’s first commercially available product, which enables clinicians to personalize GLP-1 titration at scale. Read more: www.closedloopmedicine.com/closed-loop-...

Today @enhancedgenomics.bsky.social announced it has completed a financing round, extending its total Series A funding to $19 million. The funding will be used to drive therapeutics discovery in common diseases with high unmet medical need. Read more: shorturl.at/xQdeb

Today FUJIFILM Biosciences introduced BalanCD HEK293 Perfusion A Medium, the first commercially available cell culture solution that uses a suspension of HEK293 cell and perfusion technology to streamline production of viral vectors for gene therapies. bit.ly/465mAj1

@eppendorf.bsky.social has introduced next generation mechanical pipettes. The Eppendorf Research 3 neo pipette is designed to deliver accurate and precise results for accelerated volume selection and optimised ergonomics and is now available in Asia, EMEA and the Americas. bit.ly/46lc0ED

Today, Atelerix has announced a new agreement with Rodon Global to broaden access to safe shipping and storage solutions for temperature-sensitive biomaterials, without freezing. Read the full release: bit.ly/3JGIK2t

Today @trimtechtx.bsky.social announced the formation of its Scientific Advisory Board (SAB). Professor Alessio Ciulli and Dr Adam Gilbert have been appointed as Chair and member of the SAB, respectively. Read the full press release here: shorturl.at/f76pR

Today, CN Bio announced an expansion to its Contract Research Services ADME portfolio with the addition of computational modelling capabilities to unlock deeper understanding of key ADME parameters Read more: bit.ly/4mIo7Bx

Today Qureight announced the appointment of Craig Rhodes as Head of Partnerships. Craig will lead on pharma partner relationship management and support the integration of Qureight’s platform into clinical trial workflows to advance understanding of lung & heart diseases. bit.ly/4naAohX

Today Qureight announced that its AI 3D imaging platform will be used to support Calluna Pharma’s Phase 2 study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF). The platform quantifies anatomical lung changes, providing insights into treatment efficacy. bit.ly/4lQjDrj

Bio-Rad Laboratories today announced a new range of StarBright Dyes, providing greater choice and flexibility for spectral flow cytometry in immunology research. StarBright UltraViolet700 is now available, marking the start of a broader rollout over the coming months: www.bio-rad.com/en-uk/life-s...

Bio-Rad Laboratories has launched the EZ-Check Salmonella spp. Kit for the detection of Salmonella in food and environmental samples. The kit has also been approved by AOAC International and certified NF Validation by AFNOR Certification. Read more: www.bio-rad.com/en-uk/life-s...

Camena Bioscience and Constructive Bio today announced they have joined a collaborative project led by the Max-Planck Institute of Molecular Plant Physiology, for a research initiative to develop synthetic chloroplast genomes. Read more here: rb.gy/s7s7aq

Sunil Shah (CEO, o2h Ventures) and Dr Catherine Elton (CBO, Axol Bioscience) join Atelerix's Board to drive commercial expansion and broaden access to the Company’s cell preservation solutions across major markets. Read the full press release: bit.ly/45Joe9M